Avid bioservices reports financial results for second quarter ended october 31, 2022 and recent developments

-- recorded second quarter revenue of $34.8 million -- -- signed $26 million in net new business orders resulting in a backlog of $147 million, an increase of 23% year-over-year --
CDMO Ratings Summary
CDMO Quant Ranking